DEVICE CATEGORY · PLL
Submucosal Injection Agent
Intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers or other gastrointestinal mucosal lesions, prior to excision with a snare or endoscopic device.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Endoclot Plus Co., Ltd. | 510(k) clearance | Sep 9, 2026 | FDA |
Source information
Follow the FDA links to view the original records.
